Cargando…
Phase 1 Study of the Pharmacology of BTI320 Before High‐Glycemic Meals
BTI320 is a proprietary fractionated mannan polysaccharide being studied for attenuation of postprandial glucose excursion. The apparent blood glucose‐lowering effect of this compound is effective in lowering postprandial hyperinsulinemia, participating in the metabolic regulation of other lipid mol...
Autores principales: | Luke, David R., Lee, Karen Ka Yan, Rausch, Carl W., Cheng, Camille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585810/ https://www.ncbi.nlm.nih.gov/pubmed/29870598 http://dx.doi.org/10.1002/cpdd.583 |
Ejemplares similares
-
A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetes
por: Luk, Andrea O. Y., et al.
Publicado: (2018) -
Current knowledge of BTI performance in magnetic field
por: Berdugo, Javier, et al.
Publicado: (2000) -
Transformation Index BTI 2018: governance in international comparison
por: Stiftung, Bertelsmann
Publicado: (2018) -
Transstadial Effects of Bti on Traits of Aedes aegypti and Infection with Dengue Virus
por: Alto, Barry W., et al.
Publicado: (2016) -
Long Lasting Persistence of Bacillus thuringiensis Subsp. israelensis (Bti) in Mosquito Natural Habitats
por: Tilquin, Mathieu, et al.
Publicado: (2008)